围产期抑郁症状、HIV抑制与抗逆转录病毒治疗依从性的纵向中介分析
该研究基于IMPAACT P1025围产期核心方案队列(2002-2013年)的1869名HIV感染女性,评估围产期抑郁症状对病毒抑制(VS)的影响及ART依从性的中介作用。
要点
- 围产期抑郁症状与ART依从性下降及病毒抑制失败相关。
- 抑郁症状对VS的负面效应中,ART依从性中介占比≥11%。
- 应筛查、诊断和治疗围产期抑郁以优化母婴结局。
核心结论
- 围产期抑郁症状与ART依从性下降和病毒抑制率降低独立相关。
- 抑郁症状通过ART依从性介导的间接效应占总负面效应的至少11%。
研究设计与样本
- 研究为纵向中介分析,基于IMPAACT P1025围产期核心方案队列(2002-2013年)。
- 纳入1869名HIV感染女性,47.6%为21-29岁,57.6%为非西班牙裔黑人。
- 抑郁症状采用ACTG生活质量问卷的6个条目评估,VS定义为病毒载量<400 copies/mL。
- 依从性定义为过去1-4周内无漏服,采用ACTG依从性问卷评估。
- 采用广义混合效应结构方程模型估计抑郁症状对VS的关联及ART依从性的中介作用。
主要发现
- 妊娠晚期抑郁症状平均得分为14.0(±5.2),68.0%持续依从,77.3%实现VS。
- 产后6个月抑郁症状减轻,但依从性和VS分别降至59.8%和53.0%。
- 完全调整模型中,抑郁症状每增加1个标准差,VS下降3.8个百分点(95%CI:-5.7,-1.9)。
- 抑郁症状驱动的依从性下降占抑郁症状对VS总负面效应的至少11%。
临床怎么用
- 在围产期HIV感染女性中应常规筛查抑郁症状。
- 对存在抑郁症状者应评估ART依从性并加强支持干预。
- 治疗围产期抑郁可能有助于改善病毒抑制和母婴结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women with HIV have higher risk of depressive symptoms in the perinatal period. Evidence on how perinatal depressive symptoms affect viral suppression (VS) and adherence to antiretroviral therapy (ART) remains limited. METHODS: Perinatal depressive symptoms were assessed using 6 items from the AIDS Clinical Trials Group (ACTG) Quality of Life questionnaire. VS (viral load <400 copies/mL) was the outcome. Adherence was defined as no missed dose in the past 1-4 weeks using the ACTG Adherence Questionnaire. Generalized mixed-effects structural equation models estimated the association of depressive symptoms on VS and the mediating role of ART adherence among women enrolled in the IMPAACT P1025 Perinatal Core Protocol (2002-2013). RESULTS: Among 1869 participants, 47.6% were 21-29 years, 57.6% non-Hispanic Black. In the third trimester, the mean depressive symptoms score was 14.0 (±5.2), 68.0% had consistent adherence, and 77.3% achieved VS. At 6 months postpartum, depressive symptoms declined while adherence and VS fell to 59.8% and 53.0%, respectively. In the fully adjusted model, a 1-SD increase in depressive symptoms was associated with a 3.8-percentage-point (95% CI: -5.7, -1.9) decline in VS. This effect is the sum of the indirect effect of depressive symptoms on VS via ART adherence (-0.4; 95% CI: -.7, -.2) and the direct effect through other pathways (-3.4; -5.2, -1.5). The decline in adherence driven by depressive symptoms accounted for ≥11% of the total negative effect of depressive symptoms on VS. CONCLUSIONS: Perinatal depressive symptoms were associated with decreased adherence and VS, highlighting the need to screen for, diagnose, and treat perinatal depression to optimize maternal outcomes. CLINICAL TRIALS REGISTRATION: NCT00028145.
引用
- Momplaisir F, Hussein M, Kacanek D, et al. Perinatal Depressive Symptoms, Human Immunodeficiency Virus (HIV) Suppression, and the Underlying Role of Antiretroviral Therapy Adherence: A Longitudinal Mediation Analysis in the IMPAACT P1025 Cohort. Clin Infect Dis. 2021. PMID: 33982083. doi:10.1093/cid/ciab416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。